A global survey of potential acceptance of a COVID-19 vaccine

Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazarus, Jeffrey V., Ratzan, Scott C., Palayew, Adam, Gostin, Lawrence O., Larson, Heidi J., Rabin, Kenneth, Kimball, Spencer, El-Mohandes, Ayman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573523/
https://www.ncbi.nlm.nih.gov/pubmed/33082575
http://dx.doi.org/10.1038/s41591-020-1124-9
Descripción
Sumario:Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 48.1% reported that they would accept their employer’s recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer’s advice to do so.

Ejemplares similares